87 related articles for article (PubMed ID: 17044033)
1. Alterations of hHrd1 expression are related to hyperphosphorylated tau in the hippocampus in Alzheimer's disease.
Hou HL; Shen YX; Zhu HY; Sun H; Yan XB; Fang H; Zhou JN
J Neurosci Res; 2006 Dec; 84(8):1862-70. PubMed ID: 17044033
[TBL] [Abstract][Full Text] [Related]
2. Increased p75(NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients.
Hu XY; Zhang HY; Qin S; Xu H; Swaab DF; Zhou JN
Exp Neurol; 2002 Nov; 178(1):104-11. PubMed ID: 12460612
[TBL] [Abstract][Full Text] [Related]
3. Decreased estrogen receptor-alpha expression in hippocampal neurons in relation to hyperphosphorylated tau in Alzheimer patients.
Hu XY; Qin S; Lu YP; Ravid R; Swaab DF; Zhou JN
Acta Neuropathol; 2003 Sep; 106(3):213-20. PubMed ID: 12819990
[TBL] [Abstract][Full Text] [Related]
4. Aberrant expression of the pore-forming K
Griffith CM; Xie MX; Qiu WY; Sharp AA; Ma C; Pan A; Yan XX; Patrylo PR
Neuroscience; 2016 Nov; 336():81-101. PubMed ID: 27586053
[TBL] [Abstract][Full Text] [Related]
5. A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles.
Sugata H; Matsuo K; Nakagawa T; Takahashi M; Mukai H; Ono Y; Maeda K; Akiyama H; Kawamata T
Neurosci Lett; 2009 Aug; 459(2):96-9. PubMed ID: 19414059
[TBL] [Abstract][Full Text] [Related]
6. Hyperphosphorylated tau aggregates in the cortex and hippocampus of transgenic mice with mutant human FTDP-17 Tau and lacking the PARK2 gene.
Guerrero R; Navarro P; Gallego E; Garcia-Cabrero AM; Avila J; Sanchez MP
Acta Neuropathol; 2009 Feb; 117(2):159-68. PubMed ID: 19057915
[TBL] [Abstract][Full Text] [Related]
7. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology.
Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY
Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein C-I expression in the brain in Alzheimer's disease.
Petit-Turcotte C; Stohl SM; Beffert U; Cohn JS; Aumont N; Tremblay M; Dea D; Yang L; Poirier J; Shachter NS
Neurobiol Dis; 2001 Dec; 8(6):953-63. PubMed ID: 11741391
[TBL] [Abstract][Full Text] [Related]
9. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
Teaktong T; Graham AJ; Court JA; Perry RH; Jaros E; Johnson M; Hall R; Perry EK
J Neurol Sci; 2004 Oct; 225(1-2):39-49. PubMed ID: 15465084
[TBL] [Abstract][Full Text] [Related]
10. Regional alteration of synapsin I in the hippocampal formation of Alzheimer's disease patients.
Qin S; Hu XY; Xu H; Zhou JN
Acta Neuropathol; 2004 Mar; 107(3):209-15. PubMed ID: 14673601
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
12. nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease.
Simic G; Lucassen PJ; Krsnik Z; Kruslin B; Kostovic I; Winblad B; Bogdanovi
Exp Neurol; 2000 Sep; 165(1):12-26. PubMed ID: 10964481
[TBL] [Abstract][Full Text] [Related]
13. Changes in hippocampal GABABR1 subunit expression in Alzheimer's patients: association with Braak staging.
Iwakiri M; Mizukami K; Ikonomovic MD; Ishikawa M; Hidaka S; Abrahamson EE; DeKosky ST; Asada T
Acta Neuropathol; 2005 May; 109(5):467-74. PubMed ID: 15759131
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
15. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus.
Hoozemans JJ; van Haastert ES; Nijholt DA; Rozemuller AJ; Eikelenboom P; Scheper W
Am J Pathol; 2009 Apr; 174(4):1241-51. PubMed ID: 19264902
[TBL] [Abstract][Full Text] [Related]
16. Hrd1 facilitates tau degradation and promotes neuron survival.
Shen YX; Sun AM; Fang S; Feng LJ; Li Q; Hou HL; Liu C; Wang HP; Shen JL; Luo J; Zhou JN
Curr Mol Med; 2012 Feb; 12(2):138-52. PubMed ID: 22280354
[TBL] [Abstract][Full Text] [Related]
17. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
Togo T; Dickson DW
Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha-immunoreactive astrocytes are increased in the hippocampus in Alzheimer's disease.
Lu YP; Zeng M; Hu XY; Xu H; Swaab DF; Ravid R; Zhou JN
Exp Neurol; 2003 Oct; 183(2):482-8. PubMed ID: 14552888
[TBL] [Abstract][Full Text] [Related]
19. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology.
Griffin RJ; Moloney A; Kelliher M; Johnston JA; Ravid R; Dockery P; O'Connor R; O'Neill C
J Neurochem; 2005 Apr; 93(1):105-17. PubMed ID: 15773910
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
